Primary Record
Elvitegravir
- In stock
- 952 g
- Purity
- 99.6 %
- CAS
- 697761-98-1
Compound Identifiers & Properties
- CAS
- 697761-98-1
- PubChem CID
- 5277135
- SMILES
- CC(C)[C@@H](CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O
- Canonical SMILES
- COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C
Names & Synonyms
- Elvitegravir
- Vitekta
- 697761-98-1
- elvitegravirum
- JTK-303
- GS-9137
- methscopolamine
- Elvitegravir [USAN]
- Vitekta (TN)
- Elvitegravir (GS-9137)
- GS 9137
- UNII-4GDQ854U53
- JTK303
- JTK 303
- Elvitegravir (Standard)
- Elvitegravir [USAN:INN]
- RefChem:58903
- CHEBI:72289
- AC1NQQ4E
- ELVITEGRAVIR [MI]
- C23H23CLFNO5
- Elvitegravir (JAN/USAN)
- ELVITEGRAVIR [INN]
- ELVITEGRAVIR [JAN]
- Elvitegravir(GS-9137)
- D0QD1G
- Elvitegravir (JTK-303)
- CHEMBL204656
- 4GDQ854U53
- ELVITEGRAVIR [VANDF]
- GS9137
- MFCD11846134
- ELVITEGRAVIR [MART.]
- cc-521
- MLS006011136
- ELVITEGRAVIR [WHO-DD]
- SCHEMBL726252
- DTXSID101021650
- SCHEMBL29623981
- GTPL11574
- AOB6957
- J05AX11
- VITEKTA COMPONENT ELVITEGRAVIR
- Elvitegravir (GS-9137, JTK-303)
- JUZYLCPPVHEVSV-LJQANCHMSA-N
- BCPP000242
- DTXCID101506658
- ELVITEGRAVIR [ORANGE BOOK]
- GLXC-05860
- STRIBILD COMPONENT ELVITEGRAVIR
- 697761-98-1, Pamine
- EX-A1542
- ABP000243
- BDBM50183273
- EBC-11372
- HY-14740R
- MSK159130
- s2001
- ZINC13682481
- Elvitegravir; GS9137; JTK 303
- (S)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- AKOS025396642
- ACN-050766
- BCP9000642
- CCG-269208
- CID5277135
- compound 2 [PMID: 18281931]
- CS-0439
- CS-O-11635
- DB09101
- RL04670
- CID:5277135
- KS-0000001C
- NCGC00346565-01
- NCGC00346565-04
- NCGC00346565-08
- AC-29947
- AS-16986
- BC219612
- Elvitegravir,EVG,GS-9137,JTK-303/
- HY-14740
- QC-10447
- SC-93621
- SMR004702914
- SID:459165481
- 6-(3-Chloro-2-fluorobenzyl)-1-[1(S)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- AB0008021
- EVG
- A4070
- NS00040665
- SW219721-1
- X5031
- EC-000.2332
- J2.543.801I
- A10347
- A25154
- D06677
- AB01274749-01
- AB01274749_02
- C509700
- EN300-19771136
- F547237
- 6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid
- Q2740966
- BRD-K54472332-001-01-8
- BRD-K54472332-001-03-4
- B0084-149112
- 3-Quinolinecarboxylic acid, 6-((3-chloro-2-fluorophenyl)methyl)-1,4-dihydro-1-((1S)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-
- 6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 6-(3-chloro-2-fluorobenzyl)-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1S)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic acid
- 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-; 1,4-Dihydro-6-(3-chloro-2-fluorobenzyl)-7-methoxy-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-4-oxo-3-quinolinecarboxylic acid; 6-(3-Chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Elvitegravir; GS 9137; JTK 303
- 3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-isopropyl-2-hydroxyethyl]-7-methoxy-4-oxo-
- 6-(3-Chloro-2-fluorobenzyl)-1,4-dihydro-1-[(S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic acid
- 6-(3-CHLORO-2-FLUOROBENZYL)-1-((1S)-1-(HYDROXYMETHYL)-2-METHYLPROPYL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
- 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 691-248-4
- ELV